Mind Tech Group Competitors

Lumosity is a leading brain training program, brought to you by Lumos Labs, Inc. Lumosity’s web and mobile games are designed by scientists to challenge core cognitive abilities. Lumosity’s scientists take neuropsychological and cognitive research tasks, or design new ones, and work with game designers to transform them into 50+ cognitive games. Designed to be both fun and adaptively challenging, Lumosity’s training program is accessible to people of all ages — helping them stay challenged to the full extent of their abilities. Lumos Labs also has a collaborative research initiative, the Human Cognition Project, which currently partners with over 90 university collaborators. Through the HCP, we grant qualified researchers free access to Lumosity’s cognitive training tasks, assessments, research tools, and, in some cases, limited access to data on cognitive task performance — helping them conduct larger, faster, and more efficient studies. For more information, please visit http://www.lumosity.com/hcp

EMOTIV is a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG). Our mission is to empower individuals to understand their own brain and accelerate brain research globally. Applications for the EMOTIV technology and interface span an incredible variety of industries - from gaming to interactive television, everyday computer interactions, hands-free control system, smart adaptive environments, art, accessibility design, market research, psychology, medicine, robotics, automotive, transport safety, defense and security. EMOTIV is a recognized pioneer and market leader in this field. Our products have won numerous international awards including the Red Dot Award, AutoVision Innovations Award, Australian International Design Awards, Australian Engineering Excellence Awards and Edison Awards. Our community of developers and researchers span over 120 countries.

MindMaze is a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions. MindMaze's pioneering FDA cleared and CE marked neuro-digital therapeutics accelerate patients' recovery from many critical neurological conditions. Founded in 2012 by CEO Dr Tej Tadi, MindMaze is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai.